Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evacetrapib Phase 2 in Dyslipidemia
NCT01105975Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of evacetrapib in hypercholesterolemia, dyslipidemia, sponsored by Eli Lilly and Company. Started Apr 2010; status: completed.
02
Drugs
evacetrapib
03
Conditions
hypercholesterolemiadyslipidemia
Beyond the preview
Go deeper on NCT01105975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01105975.